Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
Sonia Budroni, Francesca Buricchi, Andrea Cavallone, Patricia Bourguignon et autres
62 citationsnpj Vaccines
Patricia Bourguignon
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
22Publications signalées
1727Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
HIV Research and TreatmentImmune Cell Function and InteractionHIV/AIDS drug development and treatmentImmunotherapy and Immune ResponsesT-cell and B-cell Immunology
Publications récentes
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Milagritos D. Tapia, Samba O. Sow, B Ndiaye, Khardiata Diallo Mbaye et autres
76 citationsThe Lancet Infectious Diseases
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye, Aliou Thiongane et autres
65 citationsThe Lancet Infectious Diseases
Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon et autres
4 citationsnpj Vaccines
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon et autres
257 citationsnpj Vaccines
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults
Warren L. Dinges, Pierre‐Marie Girard, Daniel Podzamczer, Norbert H. Brockmeyer et autres
9 citationsMedicine
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial
Ying Huang, Carlos A. DiazGranados, Holly Janes, Allan C. deCamp et autres
14 citationsCurrent Opinion in Virology
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
Gloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, William Kilembe et autres
34 citationsPLoS ONE
Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines+/− Adjuvanted Protein or Electroporated DNA
Peter Hayes, Natalia Fernández, Gloria Omosa-Manyonyi, Juliet Mpendo et autres
0 citationsAIDS Research and Human Retroviruses
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients
Patricia Bourguignon, Frédéric Clément, Frédéric Renaud, Vivien Le Bras et autres
26 citationsJournal of Immunological Methods
Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
Arnaud M. Didierlaurent, Catherine Collignon, Patricia Bourguignon, Sandrine Wouters et autres
263 citationsThe Journal of Immunology
Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine
Geert Leroux‐Roels, Patricia Bourguignon, Julie Willekens, Michel Janssens et autres
15 citationsClinical and Vaccine Immunology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.